NEW YORK; April 4, 2007 -- Accenture (NYSE: ACN) recently signed a multi-year research and development (R&D) agreement with Bristol-Myers Squibb Company (NYSE: BMY), which expands the existing relationship between the two companies to include support for India-based clinical data and document management, pharmacovigilance, and scientific writing functions.
The new agreement furthers Bristol-Myers Squibb’s efforts to significantly expand its R&D capabilities in India, and is an integral part of the company’s overall global strategy of accessing top-talent around the world in support of its goal of achieving sustainable, cost-effective growth.
“This broad expansion of R&D in India will allow us to grow competitively while maintaining our industry-leading position in productivity and innovation,” said Elliott Sigal, M.D., Ph.D., executive vice president, Bristol-Myers Squibb, and chief scientific officer, president, Pharmaceutical Research Institute. “Working with Accenture, a well-respected and valued partner, Bristol-Myers Squibb will continue to access world-class talent to deliver and grow our robust product pipeline.”
Accenture will also provide maintenance and support for R&D information systems. Bristol-Myers Squibb will utilize Accenture’s well-established Life Sciences Centers of Excellence in Bangalore and Chennai, which follow industry-accepted, clinical operational practices and international standards.
“As the industry continues to face increased pressure to deliver new product innovations efficiently, leading companies are rethinking R&D operating models for sustained growth and productivity,” said Jonathan Lange, a partner in Accenture’s Health & Life Sciences practice and global lead for the company’s Clinical Services offering. “Through our R&D Centers of Excellence, we are building assets and a collaborative working model that will fuel high performance for Bristol-Myers Squibb’s R&D efforts.”
Accenture is a global management consulting, technology services and outsourcing company. Committed to delivering innovation, Accenture collaborates with its clients to help them become high-performance businesses and governments. With deep industry and business process expertise, broad global resources and a proven track record, Accenture can mobilize the right people, skills and technologies to help clients improve their performance. With more than 152,000 people in 49 countries, the company generated net revenues of US$16.65 billion for the fiscal year ended Aug. 31, 2006. Its home page is www.accenture.com.